I

Ikapharmindo Putramas Tbk PT
IDX:IKPM

Watchlist Manager
Ikapharmindo Putramas Tbk PT
IDX:IKPM
Watchlist
Price: 206 IDR -0.96% Market Closed
Market Cap: Rp347B

Ikapharmindo Putramas Tbk PT
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Ikapharmindo Putramas Tbk PT
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
I
Ikapharmindo Putramas Tbk PT
IDX:IKPM
Income from Continuing Operations
-Rp28.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Victoria Care Indonesia Tbk PT
IDX:VICI
Income from Continuing Operations
Rp136.7B
CAGR 3-Years
12%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Mustika Ratu Tbk PT
IDX:MRAT
Income from Continuing Operations
-Rp5B
CAGR 3-Years
35%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
Income from Continuing Operations
Rp1.2T
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
11%
Kino Indonesia Tbk PT
IDX:KINO
Income from Continuing Operations
Rp125.9B
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
N/A
Mandom Indonesia Tbk PT
IDX:TCID
Income from Continuing Operations
Rp15.3B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-30%
No Stocks Found

Ikapharmindo Putramas Tbk PT
Glance View

Market Cap
347B IDR
Industry
Consumer products

Ikapharmindo Putramas Tbk PT is a ID-based company operating in Personal Care Products industry. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 983 full-time employees. The company went IPO on 2023-11-08. PT Ikapharmindo Putramas Tbk. is an Indonesia-based company, which is engaged in the marketing of pharmaceutical products and consumer health products located in Jakarta, Indonesia. The firm operates through two segments: Non Pharma, Pharma, and Contract manufacturing. The firm is focused on a diverse portfolio for the Indonesian market, with brands in the pharmaceutical product categories of prescription medicines, over the counter (OTC), nutraceuticals, professional hair care products and baby products. Its prescription pharmaceuticals include neurology, dermatology, gastroenterology, and cardiology. Its consumer division products consist of professional and retail haircare products, and also Baby HUKI, which consists of baby bottles and pacifiers, and other baby feeding equipment.

IKPM Intrinsic Value
172.16 IDR
Overvaluation 16%
Intrinsic Value
Price Rp206
I

See Also

What is Ikapharmindo Putramas Tbk PT's Income from Continuing Operations?
Income from Continuing Operations
-28.8B IDR

Based on the financial report for Dec 31, 2025, Ikapharmindo Putramas Tbk PT's Income from Continuing Operations amounts to -28.8B IDR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett